The AiM Covid app developed by Dr. Vishwesh Kulkari (Warwick University UK) and has been executed to communities by Dr. Neha Sharma (UK India Chief Operating Officer) and Dr, Rekha Chaudhari (India Outreach manager), has successfully completed phase I of community screening.
At the heart of this innovation are Dr. Vishwesh Kulkarni (Warwick) and Ting Shih (ClickMedix). The app’s effectiveness lies in the presence of the all-in-one mobile-powered disease management platform of ClickMedix LLC, compliant with HIPAA and GDPR.
Aarogyam (UK) has been outreach partner with Warwick University to deploy Aim COVID-19 app and cloud-computing platform.he app has been successfully set up in South Africa and Saudi Arabia and is working efficiently since 20th March 2020. The same is now being deployed in the UK as well as in India. Primary, secondary and tertiary care facilities, home-visit community health workers, patients and their caregivers along with rural clinics are leveraging the advantages of this platform across 23 nations of the world. It is serving around 1 million patients with diseases like COVID-19, HIV/AIDS, TB and other chronic health issues that require continuous follow-ups.
The app aims to reduce the burden on the healthcare service by eliminating needless hospital visits and unnecessary consultations with the doctors or caregivers. The app has features to provide referrals to clinics, test sites and home visits apart from telemedicine services suitable to manage the patients’ conditions based on location, charge and availability. On the other hand, Machine learning (ML) helps it to calculate how the COVID-19 symptoms and severity are spreading in individuals and communities, at various levels like the city, district, state or national level. The best part is, it enforces an efficient supply chain management by ensuring that the healthcare service centres are equipped with an adequate supply of necessary personnel, gears and consumables.
More details can be found at link here